PAPP-A levels are significantly higher in patients with unstable angina or acute myocardial infarction compared to those with stable angina and healthy controls, and elevated circulating PAPP-A levels are associated with a higher risk of cardiovascular events, making it a valuable prognostic biomarker for CAD. Here, PAPPA is linked to acute myocardial infarction.